Fake papers are contaminating the world's scientific literature, fueling a corrupt industry and slowing legitimate lifesaving medical research, with an estimated 55,000 scholarly papers retracted to d ...

Even when the bogus papers are spotted – usually by amateur sleuths on their own time – academic journals are often slow to retract the papers, allowing the articles to taint what many consider ...

Global-e Online is hitting a new high Tuesday, making it one of the best stocks to buy and watch right now.

Global healthcare systems are under unprecedented strain. As life expectancies rise and populations age, the proportion of ...

ensuring wide participation from a global audience. The hybrid format will allow industry leaders, policymakers, defence experts and media who are unable to attend in person be a part of critical ...

On appeals against civilian trials under the Army Act, a seven-member constitutional bench heard the case. SC examined how the evidence was assessed in these cases, as reported by The Nation. SC ...

The lifetime risk of dementia after age 55 is about 42% — more than double the risk reported by earlier studies, and one that puts greater urgency on the need to mitigate addressable health ...

The clinical trial sector ... randomised controlled trial (RCT) model. As a result, companies have had to learn how to effectively run adaptive trial designs, while tackling small patient numbers and ...

Additionally, limertinib met its primary endpoint in a Phase 3 clinical trial comparing it to gefitinib for first-line treatment of locally advanced or metastatic NSCLC harboring EGFR mutations.

The safety profile aligned with other EGFR-targeting agents in its class. Additionally, limertinib met its primary endpoint in a Phase 3 clinical trial comparing it to gefitinib for first-line ...

Lancet Commission also calls for clinicians to no longer use Body Mass Index (BMI) alone to diagnose obesity Global ... patients and experts worldwide. The commission has recommended that obesity be ...